Q3FY23
- Consolidated revenue at Rs327.8 Cr +41% YoY
- EBITDA at Rs58.1 Cr +79 % YoY
- PAT at Rs30.6 Cr +101 % YoY
9MFY23 - Consolidated revenue at Rs1491.8 Cr + 66% YoY %
- EBITDA Rs306.5 Cr +96% YoY
- PAT at Rs200.6 Cr +202% YoY
Vimal Alawadhi, Managing Director of Best Agrolife Limited, commenting on the performance for the quarter and nine-month ended December 2022 said, “We are glad to share that despite being a lean season BAL successfully managed to remain consistent with its performance in the third quarter of this financial year. While the company has shown growth with a positive outlook across all the business segments durlng this period. We are focused on our global export expansion which wilI start
reflecting in our revenue growth soon. The company plans to introduce new and exclusive patented products like Ronfen and other different segment products which wi I scale up our growth manifolds in the coming years. lt is important to note that BAL recently obtained registration for the indigenous manufacturing of Cyhalofop-butyl and Propaquizafop Technical u/s 9(3) along with several crucial technicals”.
| Subscribe To Our Free Newsletter |
